Feb 18, 2020 · https://www.ibiology.org/development-and-stem-cells/organoidsDr. Hans Clevers provides a historical perspective on the discovery of adult stem cells in the g... Sep 14, 2020 · Correspondence to Kai Kretzschmar or Hans Clevers. Ethics declarations. Competing interests. H.C., E.D. and K.K. are named inventors on multiple patents or patents pending related to organoids. ... Johannes (Hans) Clevers (1957), M.D., Ph.D., who joined the Board of Directors in 2019, will step down from this position and be appointed the new Head of Roche pRED effective 18 March 2022.Now, a team led by Hans Clevers at the Hubrecht Institute has extended this technology to create a model of the cervix to study human papilloma virus (HPV)-mediated cervical cancer. First, the ...Abstract. Organoids are self‐organizing 3D structures grown from stem cells that recapitulate essential aspects of organ structure and function. Here, we describe a method to establish long‐term‐expanding human airway organoids from broncho‐alveolar resections or lavage material. The pseudostratified airway organoids consist of basal ...Jul 9, 2021 · 图｜丹望医疗创始团队：从左至右依次为 CEO 李俊强、CSO Hans Clevers、CTO 华国强（来源：受访者提供）. 现在，华国强除了丹望医疗创始人兼 CTO 的角色，也是复旦大学医学院教授。. 说起在纪念斯隆凯特琳癌症研究中心做博士后的那段经历，他表示，“那已经是 10 ...PMID: 19329995. DOI: 10.1038/nature07935. Abstract. The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals. We have recently … Hans Clevers obtained his MD degree in 1984 and his PhD degree in 1985 from the University Utrecht, the Netherlands. His postdoctoral work (1986-1989) was done with Cox Terhorst at the Dana-Farber Cancer Institute of the Harvard University, Boston, USA. Yotam E Bar-Ephraim # 1 , Kai Kretzschmar # 1 , Hans Clevers 2 3 Affiliations 1 Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University ... Netherlands. [email protected]. # Contributed equally. PMID: 31853049 DOI: 10.1038/s41577-019-0248-y ...Academician Professor Hans Clevers and Dr. Hong Shen, Head of Roche Innovation Center Shanghai (RICS) visited LIDE Biotech on June 9, 2021 ... Dr. Danyi Wen ( ...Is airfare really getting more expensive? It can certainly seem that way, and you might feel like it’s difficult to save money on flights these days as you’re searching for airline...There were two major similarities between the Roman Empire and Han Dynasty: the large land areas under their control and the fact that both empires peaked at around the same time i...Clevers is a member of multiple learned societies including the KNAW, the National Academy of Sciences of the USA, the Academie Francaise, the Orden pour les Merites of Germany, and the Royal Society. He holds knighthoods in Holland, France and Germany. Since March 2022, Hans is the Head of the Roche Pharmaceutical …Academician Professor Hans Clevers and Dr. Hong Shen, Head of Roche Innovation Center Shanghai (RICS) visited LIDE Biotech on June 9, 2021 ... Dr. Danyi Wen ( ... Hans Clevers obtained his MD degree in 1984 and his PhD degree in 1985 from the University Utrecht, the Netherlands. His postdoctoral work (1986-1989) was done with Cox Terhorst at the Dana-Farber Cancer Institute of the Harvard University, Bosto, USA. About. Hans Clevers obtained his MD degree in 1984 and his PhD degree in 1985 from the University Utrecht, the Netherlands. His postdoctoral work (1986-1989) was done with Cox Terhorst at the Dana-Farber Cancer Institute of the Harvard University, Boston, USA. From 1991-2002 Hans Clevers was Professor …Oct 27, 2023 · 林琳、Hans Clevers发现关系肠内分泌细胞分化的关键因子ZNF800. BioArt生物艺术 2023-10-27 15:26 浙江. 肠内分泌细胞（EEC）是存在于胃、小肠和结肠上皮中的激素分泌细胞。. 与所有其他上皮细胞系一样，EEC来源于区域特异性的Lgr5+肠干细胞。. EEC通过感知营养物质后释放 ...Mar 6, 2020 ... The 'organoid architect' Hans Clevers is combining CRISPR gene editing and organoid technologies to cure hereditary disease. ... It's amazing,« ...Oct 12, 2023 ... Dr. Hans Clevers- Organoids to model human disease ... Registration / Contact : [email protected] ... Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland, since March 2022. He was group leader at the Hubrecht Institute from 2002 until March 2022 and currently he is advisor/guest researcher at the Hubrecht Institute. The Organoid group, previously Clevers group, studies the molecular mechanisms of ... Researchers from the Organoid group (previously the Clevers group) have improved human small intestinal organoids – miniature versions of the small intestine. This will help them to better study the functioning of the small intestine during health and disease. ... Since March 2022, Hans Clevers is Head of pharma Research and Early Development ...Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland, since March 2022. He was group leader at the Hubrecht Institute from 2002 until March 2022 …Hans Clevers is obtained his MD degree in 1984 and his PhD degree in 1985 from the University Utrecht, the Netherlands. His postdoctoral work (1986-1989) was done with Cox Terhorst at the Dana-Farber Cancer Institute of the Harvard University, Boston, USA. From 1991-2002 Dr. Clevers was Professor in Immunology at the University …Jun 1, 2017 · Hans Clevers’ lab was the first to describe a true organoid as we define it today, namely the de novo development of 3D self-organizing tissue in vitro from stem cells. He and Toshiro Sato used an extracellular matrix gel, called Matrigel, to do so. Here, we describe a simple protocol to generate macroscopic intestinal tubes from small cystic organoids. Embedding proliferating organoids within a contracting floating collagen gel allows them to align and fuse to generate macroscopic hollow structures ('tubes') that are lined with a simple epithelium …Feb 3, 2022 · 荷兰科学家克莱弗斯（Hans Clevers）被任命为世界上最大的制药集团之一瑞士罗氏（Roche）的研究部门负责人。该部门包括 2200 名科学家，研究预算每年达数十亿元。 现年 64 岁的克莱弗斯原是荷兰乌特勒支大学和 Hubrecht 研究所等机 …Starting on the 18 th of March, Hans Clevers, group leader at the Hubrecht Institute, will head the Roche Pharma Research and Early Development (pRED) and become a …Feb 3, 2022 · 荷兰科学家克莱弗斯（Hans Clevers）被任命为世界上最大的制药集团之一瑞士罗氏（Roche）的研究部门负责人。该部门包括 2200 名科学家，研究预算每年达数十亿元。 现年 64 岁的克莱弗斯原是荷兰乌特勒支大学和 Hubrecht 研究所等机 …May 14, 2009 · Abstract. The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals. We have recently demonstrated the presence of about six cycling Lgr5 (+) stem cells at the bottoms of small-intestinal crypts. Here we describe the establishment of long-term culture conditions under which single crypts …Apr 12, 2022 · Our lab is led by Prof. Nicolas Papernot and is located at the University of Toronto and the Vector Institute, both located in downtown Toronto (Canada). Get to know our team by browsing our list of current and past members, and if you are interested in joining please read the following page.Jun 7, 2013 · Hans Clevers * [email protected] Hubrecht Institute–Koninklijke Nederlandse Akademie van Wetenschappen and University Medical Centre Utrecht, Uppsalalaan 8, 3584CT, Utrecht, Netherlands. View all articles by this authorJan 11, 2024 · Cell | Hans Clevers领导课题组首次利用人类胎儿脑组织培育出了大脑类器官. 科学家们利用人类胎儿脑组织开发出可在体外自我组装的三维微型器官。. 这些在实验室培育的类器官为研究大脑如何发育开辟了一条全新的途径。. 它们还为研究与大脑发育有关的疾病 ... Clevers is a member of multiple learned societies including the KNAW, the National Academy of Sciences of the USA, the Academie Francaise, the Orden pour les Merites of Germany, and the Royal Society. He holds knighthoods in Holland, France and Germany. Since March 2022, Hans is the Head of the Roche Pharmaceutical Research and Early ... Birthdays are a time for celebration, laughter, and joy. Birthdays can sometimes be bittersweet reminders of getting older, but injecting some humor into the festivities can turn a...Dec 19, 2023 · 全新首页 焕新登场. Hans Clevers合作团队新进展！. Nauture子刊：具备免疫系统的类器官可评估肿瘤免疫治疗脱靶效应. 通过招募免疫细胞靶向肿瘤，癌症免疫治疗已成为目前对抗癌症最有前途的策略之一。. 尽管显示出良好的临床疗效，但由于癌症细胞和免疫抑制 ...In 2009 the laboratory of Hans Clevers was the first to describe the AdSC-derived organoid system. ... Sato T, Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell ...Jun 13, 2017 ... The International Society for Stem Cell Research (ISSCR) is pleased to announce Hans Clevers, Hubrecht Institute, the Netherlands, ...When it comes to suburban living, many homeowners face the challenge of making the most out of limited space. This is particularly true when it comes to bedrooms, where maximizing ...Johannes (Hans) Clevers (1957), M.D., Ph.D., who joined the Board of Directors in 2019, will step down from this position and be appointed the new Head of Roche pRED effective 18 March 2022.Hans Clevers 1 Affiliation 1 Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, The Netherlands. [email protected]; PMID: 21386835 DOI: 10.1038/nm.2304 Abstract Over the last decade, the notion that tumors are maintained by their own stem cells, the so-called …Abstract. In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding epithelial organoids that retain their tissue identity. We report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma (CRC) patients. For most, organoids were also generated from adjacent normal tissue.Hans Clevers is a molecular biologist and immunologist who studies the molecular mechanisms of tissue development and cancer of various organs using organoids made …Correspondence to Hans Clevers. Ethics declarations. Competing interests. H.C. is an inventor on several patents involving the culture system in this paper, as is T.S. ...28 August 2017. Hans Clevers. The scientific journal Science publishes an extensive story about how professor Hans Clevers came to his pioneering work with mini-organs (so-called organoids). For Clevers, the bonanza has come as a surprise. A basic biologist at heart, he says he never had real-world applications in mind.The cell theory states that the cell is the basic unit of life. Hans and Zacharias Jansen greatly contributed to the various parts of this theory by inventing the first microscope....Johanna F. Dekkers, Jens Puschhof, Maarten H. Geurts, Else Driehuis, Rosemary Millen, Oded Kopper, Yotam E. Bar-Ephraim, Kai Kretzschmar & Hans …Oct 14, 2007 · Correspondence to Hans Clevers. Ethics declarations. Competing interests. H. Clevers is an inventor on several patents involving Wnt target genes, as is N. Barker. ...We now describe conditions allowing long-term expansion of adult bile duct-derived bipotent progenitor cells from human liver. The expanded cells are highly stable at the chromosome and structural level, while single base changes occur at very low rates. The cells can readily be converted into functional hepatocytes in vitro and upon ...View the profiles of professionals named "Hans Clevers" on LinkedIn. There are 3 professionals named "Hans Clevers", who use LinkedIn to exchange ...OC organoids recapitulate histological and genomic features of the pertinent lesion from which they were derived, illustrating intra- and interpatient heterogeneity, and can be genetically modified. We show that OC organoids can be used for drug-screening assays and capture different tumor subtype responses to the gold …Sep 21, 2022 · 2009年，荷兰科学家Hans Clevers团队在体外成功地将小鼠Lgr5+肠道干细胞培养成小鼠小肠类器官（mSIOs ），这种类器官模型重现了隐窝样区域和绒毛样上皮区域的三维结构。通过 …In 2009 the laboratory of Hans Clevers was the first to describe the AdSC-derived organoid system. ... Sato T, Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell ...Our lab is led by Prof. Nicolas Papernot and is located at the University of Toronto and the Vector Institute, both located in downtown Toronto (Canada). Get to know our team by browsing our list of current and past members, and if you are interested in joining please read the following page.This Paneth cell requirement can be substituted by a pulse of exogenous Wnt. Genetic removal of Paneth cells in vivo results in the concomitant loss of Lgr5 stem cells. In colon crypts, CD24 (+) cells residing between Lgr5 stem cells may represent the Paneth cell equivalents. We conclude that Lgr5 stem cells compete for essential niche signals ...These authors jointly supervised this work: Bart L. Haagmans, Hans Clevers. Authors and Affiliations Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and ...Hans Clevers is a molecular biologist and immunologist who studies the molecular mechanisms of tissue development and cancer of various organs using organoids made …Aug 28, 2017 · 28 August 2017. Hans Clevers. The scientific journal Science publishes an extensive story about how professor Hans Clevers came to his pioneering work with mini-organs (so-called organoids). For Clevers, the bonanza has come as a surprise. A basic biologist at heart, he says he never had real-world applications in mind. Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland, since March 2022. He was group leader at the Hubrecht Institute from 2002 until March 2022 and currently he is advisor/guest researcher at the Hubrecht Institute. The Organoid group, previously Clevers group, studies the molecular mechanisms of ... Monk fruit, also known as Luo Han Guo, is a small green gourd-like fruit native to Southeast Asia. While it has gained popularity in recent years as a natural sweetener with zero c...Hans C. Clevers | ScienceDirect. Author information. Current affiliation: University Medical Center Utrecht, Utrecht, Netherlands. Scopus ID: 35594209900. 177,293. Citations from …Else Driehuis , Kai Kretzschmar , Hans Clevers Adult stem cell–based organoid technology is a versatile tool for the generation and long-term maintenance of near-native 3D epithelial tissues in vitro.Tuveson, D. & Clevers, H. Cancer modeling meets human organoid technology. Science 364, 952–955 (2019). Kretzschmar, K. & Clevers, H. Organoids: modeling development and the stem cell niche in a dish. Dev. Cell 38, 590–600 (2016). Dye, B. R. et al. In vitro generation of human pluripotent stem cell derived lung organoids.Oct 26, 2023 · Optimized human SI organoids exhibit the spontaneous generation of all major cell lineages, including EEC subtypes, without TF overexpression ().For the current study, we aimed to establish a CRISPR screening platform spanning the entire repertoire of transcription factors (TFome) in human intestinal organoids to …4 days ago · Hans Clevers团队成功建立首个人类胎儿大脑衍生类器官. 盛合瑞类器官. 类器官，作为医学研究领域的崭新工具，自诞生以来便在科学界引起了广泛的关注。. 在模拟人类胎儿大脑自组织生长的过程中，类器官所展现的细胞多样性和扩展能力，无疑昭示着其巨大的 ...View the profiles of professionals named "Hans Clevers" on LinkedIn. There are 3 professionals named "Hans Clevers", who use LinkedIn to exchange ...In recent years, online education has become increasingly popular, and for good reason. With the advancement of technology, students now have the opportunity to enroll in clever on...Bon-Kyoung Koo 1 , Hans Clevers 2 Affiliations 1 Wellcome Trust - Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, England; Department of Genetics, University of Cambridge, Cambridge, England. 2 Hubrecht Institute/KNAW, Utrecht, The Netherlands; University Medical Center Utrecht, Utrecht, The Netherlands ...Using the precise genome-editing capabilities of the CRISPR/Cas9 system, Hans Clevers and colleagues have introduced four of the most common colorectal cancer mutations into human organoid ...Hans Clevers. Nature Biotechnology 41 , 1567–1581 ( 2023) Cite this article. 40k Accesses. 28 Citations. 185 Altmetric. Metrics. Abstract. The lack of registered drugs …Feb 2, 2022 · Hans Clevers教授 （来源：罗氏官网） 体外培养类器官的想法和尝试由来已久，但重要的突破发生在2009年。 荷兰科学家Hans Clevers教授在这一方面做出了重要开创性的贡献，最先提出类器官概念，并发现了从多种上皮组织（epithelia）在体外培养干细胞及衍生的“微型器官”（HUB类器官）的方法。Clevers is a member of multiple learned societies including the KNAW, the National Academy of Sciences of the USA, the Academie Francaise, the Orden pour les Merites of Germany, and the Royal Society. He holds knighthoods in Holland, France and Germany. Since March 2022, Hans is the Head of the Roche Pharmaceutical …Mar 6, 2020 ... The 'organoid architect' Hans Clevers is combining CRISPR gene editing and organoid technologies to cure hereditary disease. ... It's amazing,« ...May 14, 2015 · Hans Clevers, Eric Bender. PMID: 25970453 DOI: 10.1038/521S15a No abstract available. Publication types Interview MeSH terms Adult Stem Cells / metabolism ... Hans Clevers is a Distinguished Professor at Utrecht University and a group leader at the Hubrecht Institute (KNAW). He is also group leader of the Princess Máxima Center for pediatric oncology ...Wnt signaling had a synergistic effect with the Lgr4/5 ligand R-spondin to induce formation of Paneth cells. Mosaic expression of Wnt3 in organoids using a retroviral vector promoted differentiation of Paneth cells in a cell-autonomous manner. Conclusions: Wnt is part of a signaling loop that affects homeostasis of intestinal stem and Paneth ...In recent years, online education has become increasingly popular, and for good reason. With the advancement of technology, students now have the opportunity to enroll in clever on...Jan 19, 2021 · Realizing the potential of organoids—an interview with Hans Clevers. The past decade has witnessed the development of a powerful new model to study human disease: stem cell–derived organoids. These are 3-dimensional structures recapitulating the architecture of an organ in miniature. Because they can be …“My belief is that human organoids have the potential to complement most of what we do in R&D,” says Hans Clevers, Head of Pharma Research and Early Development at Roche and a pioneer in the field of organoids. “I'm convinced that one can implement human organoids at every step of the way — from target identification …Jun 23, 2020 · Hans Clevers通过培养肠道中存活的干细胞，开发出历史上第一个类器官，其与体内来源的组织或器官高度相似。. 类器官可以从许多类组织中培养出来，用于研究各种人体器官的生理功能和病理特征，对于研发新药和个性化的治疗方案具有巨大潜力。. Hans Clevers教授 ...Dec 31, 2020 · Hans Clevers. Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria. Juergen A. Knoblich. Aug 25, 2017 · Clevers and others have since grown organoids from many other organs, including the stomach, pancreas, brain, and liver. Easy to manipulate, organoids are clarifying how tissues develop and repair injury. But perhaps most exciting, many researchers say, is their ability to model diseases in new ways. May 13, 2015 · In 2009, Hans Clevers and Toshiro Sato (then a postdoc in Clevers' lab) demonstrated a powerful new model to study development and disease: a three-dimensional 'organoid' derived from adult stem ... Wnt signaling had a synergistic effect with the Lgr4/5 ligand R-spondin to induce formation of Paneth cells. Mosaic expression of Wnt3 in organoids using a retroviral vector promoted differentiation of Paneth cells in a cell-autonomous manner. Conclusions: Wnt is part of a signaling loop that affects homeostasis of intestinal stem and Paneth ...Professor Clevers received his Ph.D degree from the University of Utrecht in 1985. He has received several scientific prizes, including The Academy Professor Prize of the Royal Netherlands Academy, the Ilse & Helmut Wachter award, the Keio Medical Science Prize, the Citation Laureate, the Pezcoller … Hans Clevers is a Distinguished Professor at Utrecht University and guest scientist/advisor at the Hubrecht Institute (KNAW). He is also guest scientist/advisor of the Princess Máxima Center for pediatric oncology and Oncode Investigator. Hans Clevers's stem-cell research plays a prominent role within the Utrecht strategic research theme Life ... May 14, 2009 · Abstract. The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals. We have recently demonstrated the presence of about six cycling Lgr5 (+) stem cells at the bottoms of small-intestinal crypts. Here we describe the establishment of long-term culture conditions under which single crypts …This isHUB Organoids. HUB Organoids is the global leader in patient-derived organoid technology. Our patented technology enables drug developers to identify and validate clinical candidates in a patient-relevant in vitro system. We disrupt the status quo and deliver superior therapeutic solutions to the world by bridging the …Sep 7, 2016 ... Prof. Hans Clevers says researchers should be open about their work and they'll be trusted in return.
Sep 27, 2020 · 国际类器官鼻祖Hans Clevers院士 Hans Clevers教授是成体干细胞与类器官技术领域大师级的科学家，是美国和英国皇家国家科学院院士，荷兰皇家科学院院士。Hans Clevers教授发现Lgr5是肠道干细胞的标志物，并成功建立首个肠道干细胞体外3D类器官培养。. Home workouts app
From 1991–2002 Hans Clevers was Professor in Immunology at the University Utrecht and, since 2002, Professor in Molecular Genetics. From 2002–2012 he was director of the Hubrecht Institute in Utrecht. From 2012-2015 he was President of the Royal Netherlands Academy of Arts and Sciences (KNAW). …Sep 17, 2020 ... Joep Beumer: Methodology. Hans Clevers: Funding acquisition; project administration; supervision. Literature Cited. Hans Clevers is the leader of the Organoid group, formerly known as the Clevers group, at the Hubrecht Institute. He studies the molecular mechanisms of tissue development and cancer using organoids made from adult Lgr5 stem cells, a discovery that he pioneered. Learn more about his research, publications, awards, and activities. Else Driehuis , Kai Kretzschmar , Hans Clevers Adult stem cell–based organoid technology is a versatile tool for the generation and long-term maintenance of near-native 3D epithelial tissues in vitro.Affiliations 1 Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, 3584 CT Utrecht, The Netherlands; email: [email protected].; 2 Department of Pathology, Amsterdam University Medical Centers, Location VU Medical Center, 1081 HV Amsterdam, The Netherlands.; 3 Princess Máxima …Else Driehuis , Kai Kretzschmar , Hans Clevers Adult stem cell–based organoid technology is a versatile tool for the generation and long-term maintenance of near-native 3D epithelial tissues in vitro.Johanna F. Dekkers, Maria Alieva, Lianne M. Wellens, Hendrikus C. R. Ariese, Ellen J. Wehrens, Hans Clevers & Anne C. Rios. Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW ...Jun 7, 2013 · Hans Clevers * [email protected] Hubrecht Institute–Koninklijke Nederlandse Akademie van Wetenschappen and University Medical Centre Utrecht, Uppsalalaan 8, 3584CT, Utrecht, Netherlands. View all articles by this authorProfessor in Molecular Genetics, University of Utrecht, NL. Principal Investigator of a research group of ~40 scientists at the Hubrecht Institute, Utrecht, NL. President of the Royal Netherlands Academy of Sciences, Utrecht, NL. Director Research of the Princess Máxima Center for Pediatric Oncology, Utrecht, NL. Prof.dr. Hans Clevers. Distinguished University Professor. Medicine. Profile CV Ancillary activities Research Honours and awards Contact. 7 University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, the Netherlands. [email protected]. 8 The Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands. [email protected] holiday season is just around the corner, and it’s time to start thinking about sprucing up your home with festive decorations. However, decorating for Christmas can often put ...Living in a small apartment can be a challenge, especially when it comes to finding enough space for all your belongings. However, with some clever design tips, you can make the mo...Hans Clevers is a Distinguished Professor at Utrecht University and a group leader at the Hubrecht Institute (KNAW). He is also group leader of the Princess Máxima Center for pediatric oncology ...Hans and Zacharias Janssen were a Dutch father and son accredited with the creation of the first microscope. Both lived in the Netherlands and were working with each other as spect...Is airfare really getting more expensive? It can certainly seem that way, and you might feel like it’s difficult to save money on flights these days as you’re searching for airline...When you’re ready to bake up a storm in the kitchen, there’s nothing more frustrating than discovering that your brown sugar has hardened into a solid brick. But fear not. We have ...Till Ringel 1 , Nina Frey 2 , Femke Ringnalda 2 , Sharan Janjuha 1 , Sarah Cherkaoui 3 , Stefan Butz 4 , Sumana Srivatsa 5 , Martin Pirkl 5 , Giancarlo Russo 6 , Lukas Villiger 2 , Gerhard Rogler 7 , Hans Clevers 8 , Niko Beerenwinkel 5 , Nicola Zamboni 3 , Tuncay Baubec 4 , Gerald Schwank 9Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland, since March 2022. He was group leader at the Hubrecht Institute from 2002 until March 2022 ….